
David Browe
Examiner (ID: 4079)
| Most Active Art Unit | 1617 |
| Art Unit(s) | 1616, 1617 |
| Total Applications | 918 |
| Issued Applications | 187 |
| Pending Applications | 110 |
| Abandoned Applications | 639 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5522209
[patent_doc_number] => 20090030190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => 'siRNA targeting 1-acylglycerol-3-phosphate O-acyltransferase 2 (AGPAT2)'
[patent_app_type] => utility
[patent_app_number] => 11/881768
[patent_app_country] => US
[patent_app_date] => 2007-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 34094
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0030/20090030190.pdf
[firstpage_image] =>[orig_patent_app_number] => 11881768
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/881768 | siRNA targeting 1-acylglycerol-3-phosphate O-acyltransferase 2 (AGPAT2) | Jul 26, 2007 | Abandoned |
Array
(
[id] => 5350186
[patent_doc_number] => 20090005547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-01
[patent_title] => 'siRNa targeting neuropilin 1 (NRP1)'
[patent_app_type] => utility
[patent_app_number] => 11/881771
[patent_app_country] => US
[patent_app_date] => 2007-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 34750
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20090005547.pdf
[firstpage_image] =>[orig_patent_app_number] => 11881771
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/881771 | siRNa targeting neuropilin 1 (NRP1) | Jul 26, 2007 | Abandoned |
Array
(
[id] => 5086084
[patent_doc_number] => 20070276135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-29
[patent_title] => 'siRNA targeting dual specificity phosphate 5 (DUSP5)'
[patent_app_type] => utility
[patent_app_number] => 11/810074
[patent_app_country] => US
[patent_app_date] => 2007-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 34523
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0276/20070276135.pdf
[firstpage_image] =>[orig_patent_app_number] => 11810074
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/810074 | siRNA targeting dual specificity phosphate 5 (DUSP5) | Jun 3, 2007 | Abandoned |
Array
(
[id] => 5248077
[patent_doc_number] => 20070244311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-18
[patent_title] => 'siRNA targeting coatomer protein complex, subunit beta 2 (CPOB2)'
[patent_app_type] => utility
[patent_app_number] => 11/807836
[patent_app_country] => US
[patent_app_date] => 2007-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 34783
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20070244311.pdf
[firstpage_image] =>[orig_patent_app_number] => 11807836
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/807836 | siRNA targeting coatomer protein complex, subunit beta 2 (COPB2) | May 29, 2007 | Issued |
Array
(
[id] => 4705341
[patent_doc_number] => 20080064865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-13
[patent_title] => 'siRNA targeting cyclin dependent kinase 11 (CDK11)'
[patent_app_type] => utility
[patent_app_number] => 11/807486
[patent_app_country] => US
[patent_app_date] => 2007-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 35699
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20080064865.pdf
[firstpage_image] =>[orig_patent_app_number] => 11807486
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/807486 | siRNA targeting cyclin dependent kinase 11 (CDK11) | May 28, 2007 | Issued |
Array
(
[id] => 4802604
[patent_doc_number] => 20080014191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-17
[patent_title] => 'Treatment of Protein Misfolding'
[patent_app_type] => utility
[patent_app_number] => 11/751528
[patent_app_country] => US
[patent_app_date] => 2007-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 33445
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20080014191.pdf
[firstpage_image] =>[orig_patent_app_number] => 11751528
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/751528 | Treatment of Protein Misfolding | May 20, 2007 | Abandoned |
Array
(
[id] => 4935
[patent_doc_number] => 07812150
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-12
[patent_title] => 'RNAi modulation of Aha and therapeutic uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/750553
[patent_app_country] => US
[patent_app_date] => 2007-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32451
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/812/07812150.pdf
[firstpage_image] =>[orig_patent_app_number] => 11750553
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/750553 | RNAi modulation of Aha and therapeutic uses thereof | May 17, 2007 | Issued |
Array
(
[id] => 4939412
[patent_doc_number] => 20080076731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-27
[patent_title] => 'Control of NK cell function and survival by modulation of ship activity'
[patent_app_type] => utility
[patent_app_number] => 11/787064
[patent_app_country] => US
[patent_app_date] => 2007-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 15432
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20080076731.pdf
[firstpage_image] =>[orig_patent_app_number] => 11787064
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/787064 | Control of NK cell function and survival by modulation of SHIP activity | Apr 12, 2007 | Issued |
Array
(
[id] => 5199935
[patent_doc_number] => 20070299253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-27
[patent_title] => 'siRNA targeting vacuolar ATPase'
[patent_app_type] => utility
[patent_app_number] => 11/731875
[patent_app_country] => US
[patent_app_date] => 2007-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 34943
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20070299253.pdf
[firstpage_image] =>[orig_patent_app_number] => 11731875
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/731875 | siRNA targeting vacuolar ATPase | Mar 29, 2007 | Abandoned |
Array
(
[id] => 5247833
[patent_doc_number] => 20070244067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-18
[patent_title] => 'DEVICES AND PROCESSES FOR DISTRIBUTION OF GENETIC MATERIAL TO MAMMALIAN LIMB'
[patent_app_type] => utility
[patent_app_number] => 11/694140
[patent_app_country] => US
[patent_app_date] => 2007-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18211
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20070244067.pdf
[firstpage_image] =>[orig_patent_app_number] => 11694140
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/694140 | Devices and processes for distribution of genetic material to mammalian limb | Mar 29, 2007 | Issued |
Array
(
[id] => 5102055
[patent_doc_number] => 20070185317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'siRNA targeting HtrA serine peptidase 1'
[patent_app_type] => utility
[patent_app_number] => 11/729388
[patent_app_country] => US
[patent_app_date] => 2007-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 34681
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20070185317.pdf
[firstpage_image] =>[orig_patent_app_number] => 11729388
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/729388 | siRNA targeting HtrA serine peptidase 1 | Mar 27, 2007 | Abandoned |
Array
(
[id] => 4965232
[patent_doc_number] => 20080108052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-08
[patent_title] => 'Use of Ribozymes in the Detection of Adventitious Agents'
[patent_app_type] => utility
[patent_app_number] => 11/691904
[patent_app_country] => US
[patent_app_date] => 2007-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7651
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20080108052.pdf
[firstpage_image] =>[orig_patent_app_number] => 11691904
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/691904 | Use of Ribozymes in the Detection of Adventitious Agents | Mar 26, 2007 | Abandoned |
Array
(
[id] => 5230768
[patent_doc_number] => 20070292875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-20
[patent_title] => 'Human RNase H1 oligonucleotide compositions thereof'
[patent_app_type] => utility
[patent_app_number] => 11/726598
[patent_app_country] => US
[patent_app_date] => 2007-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 41816
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20070292875.pdf
[firstpage_image] =>[orig_patent_app_number] => 11726598
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/726598 | Human RNase H1 oligonucleotide compositions thereof | Mar 20, 2007 | Abandoned |
Array
(
[id] => 5220285
[patent_doc_number] => 20070161596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-12
[patent_title] => 'RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER\'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA)'
[patent_app_type] => utility
[patent_app_number] => 11/684465
[patent_app_country] => US
[patent_app_date] => 2007-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 71940
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20070161596.pdf
[firstpage_image] =>[orig_patent_app_number] => 11684465
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/684465 | RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA) | Mar 8, 2007 | Abandoned |
Array
(
[id] => 5231549
[patent_doc_number] => 20070293657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-20
[patent_title] => 'COMPLEXES AND METHODS OF FORMING COMPLEXES OF RIBONUCLEIC ACIDS AND PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 11/670905
[patent_app_country] => US
[patent_app_date] => 2007-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22709
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20070293657.pdf
[firstpage_image] =>[orig_patent_app_number] => 11670905
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/670905 | COMPLEXES AND METHODS OF FORMING COMPLEXES OF RIBONUCLEIC ACIDS AND PEPTIDES | Feb 1, 2007 | Abandoned |
Array
(
[id] => 5199709
[patent_doc_number] => 20070299027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-27
[patent_title] => 'COMPOSITIONS AND THEIR USES DIRECTED TO HUNTINGTIN'
[patent_app_type] => utility
[patent_app_number] => 11/627921
[patent_app_country] => US
[patent_app_date] => 2007-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22518
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20070299027.pdf
[firstpage_image] =>[orig_patent_app_number] => 11627921
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/627921 | COMPOSITIONS AND THEIR USES DIRECTED TO HUNTINGTIN | Jan 25, 2007 | Abandoned |
Array
(
[id] => 5225096
[patent_doc_number] => 20070254362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-01
[patent_title] => 'COMPOSITIONS AND METHODS EMPLOYING UNIVERSAL-BINDING NUCLEOTIDES FOR TARGETING MULTIPLE GENE VARIANTS WITH A SINGLE siRNA DUPLEX'
[patent_app_type] => utility
[patent_app_number] => 11/610403
[patent_app_country] => US
[patent_app_date] => 2006-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13778
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20070254362.pdf
[firstpage_image] =>[orig_patent_app_number] => 11610403
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/610403 | COMPOSITIONS AND METHODS EMPLOYING UNIVERSAL-BINDING NUCLEOTIDES FOR TARGETING MULTIPLE GENE VARIANTS WITH A SINGLE siRNA DUPLEX | Dec 12, 2006 | Abandoned |
Array
(
[id] => 4976890
[patent_doc_number] => 20070218122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'siRNA silencing of influenza virus gene expression'
[patent_app_type] => utility
[patent_app_number] => 11/601437
[patent_app_country] => US
[patent_app_date] => 2006-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 33902
[patent_no_of_claims] => 111
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0218/20070218122.pdf
[firstpage_image] =>[orig_patent_app_number] => 11601437
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/601437 | siRNA silencing of influenza virus gene expression | Nov 16, 2006 | Abandoned |
Array
(
[id] => 4983432
[patent_doc_number] => 20070087991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-19
[patent_title] => 'Pluripotential stem cells'
[patent_app_type] => utility
[patent_app_number] => 11/600125
[patent_app_country] => US
[patent_app_date] => 2006-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 21988
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20070087991.pdf
[firstpage_image] =>[orig_patent_app_number] => 11600125
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/600125 | Pluripotential stem cells | Nov 15, 2006 | Abandoned |
Array
(
[id] => 4989317
[patent_doc_number] => 20070155658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-05
[patent_title] => 'NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS AND STABLE DOUBLE-STRANDED RNA'
[patent_app_type] => utility
[patent_app_number] => 11/557457
[patent_app_country] => US
[patent_app_date] => 2006-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9016
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20070155658.pdf
[firstpage_image] =>[orig_patent_app_number] => 11557457
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/557457 | NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS AND STABLE DOUBLE-STRANDED RNA | Nov 6, 2006 | Abandoned |